Literature DB >> 24300008

Transvenous embolization with onyx for cavernous sinus dural arteriovenous fistula. A report of two cases.

Chuhan Jiang1, Xianli Lv, Youxiang Li, Aihua Liu, Zhongxue Wu.   

Abstract

Previous treatments for cavernous dural arteriovenous fistulas (DAVF) include transarterial embolization with NBCA and transvenous embolization with platinum coils. This paper presents two cases of cavernous sinus dural arterial venous fistula successfully treated via a transvenous approach with Onyx. Case 1. A 54-year-old man presented with blepharotosis, diplopia and chemosis. Cerebral angiography demonstrated a cavernous DAVF, which was successfully treated via inferior petrosal sinus with a combination of Onyx and platinum coils. Case 2. A 36-year-old woman was admitted after incomplete transarterial embolization of a dural cavernous fistula. The patien's symptoms resolved almost completely after embolization with Onyx-34 via the superior ophthalmic vein. To our knowledge, only two such cases have been reported in the literature. The advantages of Onyx make it an attractive alternative to the various platinum coils already described.

Entities:  

Year:  2007        PMID: 24300008     DOI: 10.1177/197140090702000617

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  3 in total

Review 1.  Anatomic variations of internal jugular vein, inferior petrosal sinus and its confluence pattern: Implications in inferior petrosal sinus catheterization.

Authors:  Xianli Lv; Zhongxue Wu
Journal:  Interv Neuroradiol       Date:  2015-09-16       Impact factor: 1.610

2.  A promising adjuvant to detachable coils for cavernous packing: onyx.

Authors:  X Lv; C Jiang; Y Li; Z Wu
Journal:  Interv Neuroradiol       Date:  2009-09-01       Impact factor: 1.610

3.  Percutaneous Transvenous Embolization of Intracranial Dural Arteriovenous Fistulas with Detachable Coils and/or in Combination with Onyx.

Authors:  Xianli Lv; Chuhan Jiang; Youxiang Li; Xinjian Yang; Zhongxue Wu
Journal:  Interv Neuroradiol       Date:  2009-01-05       Impact factor: 1.610

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.